Sandoz Group AG

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Public

Established: 1986-01-01

Employees: 20K

Market Cap: $19B

Website: http://www.sandoz.com

Clinical Trials

To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Clomipramine Hydrochloride 25 mg Capsules (Geneva Pharmaceuticals)
Drug: Anafranil Clomipramine Hydrochloride 25 mg Capsules (Basel)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 36

Registration Number: NCT00913783

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions

Phase 1

Completed

Conditions: Inflammation

Interventions: Drug: Diclofenac Sodium 75 mg Tablets Under Fasting Conditions (Geneva Pharmaceutical)
Drug: Diclofenac Sodium 75 mg Tablets Under Fed Conditions (Geneva Pharmaceutical)
Drug: Voltaren 75 mg Tablets Under Fed Conditions (Geigy Pharmaceuticals)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 18

Registration Number: NCT00913887

To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting Conditions

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Prozac Fluoxetine Hydrochloride 20 mg Capsules (Dista)
Drug: Fluoxetine Hydrochloride 20 mg Capsules (Geneva Pharmaceutical, Inc.)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 46

Registration Number: NCT00913718

To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Cyclobenzaprine HCl Tablets 10 mg, Cord Laboratories
Drug: Cyclobenzaprine HCl Tablets 10 mg, Merck Sharp & Dohme

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 30

Registration Number: NCT00913419

To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted Conditions

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Prozac Fluoxetine HCl 20 mg Capsules Under Fed Conditions (Dista)
Drug: Fluoxetine HCl 20 mg Capsules Under Fasting Conditions (Geneva Pharmaceutical, Inc.)
Drug: Fluoxetine HCl 20 mg Capsules Under Fed Conditions (Geneva Pharmaceutical, Inc.)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 24

Registration Number: NCT00913588

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets

Phase 1

Completed

Conditions: Inflammation

Interventions: Drug: Voltaren 50 mg Tablets (Geigy Pharmaceuticals)
Drug: Diclofenac Sodium 50 mg Tablets (Geneva Pharmaceuticals, Inc)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 38

Registration Number: NCT00913224

To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets

Phase 1

Completed

Conditions: Depression

Interventions: Drug: Desipramine Hydrochloride 50 mg Tablets (Merrell Dow Pharmaceuticals, Inc)
Drug: Desipramine Hydrochloride 50 mg Tablets (Cord Laboratories)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 36

Registration Number: NCT00913237

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg

Phase 1

Completed

Conditions: Anxiety

Interventions: Drug: Alprazolam Tablets, 1 mg (Geneva Pharmaceuticals)
Drug: Alprazolam Tablets, 1 mg (The Upjohn Company)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 30

Registration Number: NCT00913341

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting Conditions

Phase 1

Completed

Conditions: Inflammation

Interventions: Drug: Diclofenac Sodium 50 mg Tablets Under Fasting Conditions (Geneva Pharmaceuticals, Inc)
Drug: Diclofenac Sodium 50 mg Tablets Under Fed Conditions (Geneva Pharmaceuticals, Inc)
Drug: Voltaren 50 mg Tablets Under Fed Conditions (Geigy Pharmaceuticals)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 18

Registration Number: NCT00914160

To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions

Phase 1

Completed

Conditions: Bipolar Disorder
Epilepsy

Interventions: Drug: Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA)
Drug: Depakote 500 mg DR Tablets (Abbott Laboratories, USA)

First Posted Date: 2009-06-04

Last Posted Date: 2017-03-28

Lead Sponsor: Sandoz

Target Recruit Count: 30

Registration Number: NCT00913848

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy